{"id":2962,"date":"2024-10-11T06:44:13","date_gmt":"2024-10-11T06:44:13","guid":{"rendered":"https:\/\/vichsec.org\/guidline\/the-supplement-explanatory-document-to-vich-gl52\/"},"modified":"2024-10-24T09:03:20","modified_gmt":"2024-10-24T09:03:20","slug":"the-supplement-explanatory-document-to-vich-gl52","status":"publish","type":"guideline","link":"https:\/\/vichsec.org\/fr\/guidline\/the-supplement-explanatory-document-to-vich-gl52\/","title":{"rendered":"Bioquivalence: Blood Level Bioequivalence Study"},"content":{"rendered":"<p>VICH GL52 (Bioequivalence) &#8211; October 2015 &#8211; Implemented in August 2016<\/p>\n","protected":false},"menu_order":52,"template":"","meta":[],"guideline_category":[230],"class_list":["post-2962","guideline","type-guideline","status-publish","hentry","guideline_category-pharmaceuticals-pharma-efficacy-bioequivalence-fr"],"_links":{"self":[{"href":"https:\/\/vichsec.org\/fr\/wp-json\/wp\/v2\/guideline\/2962","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/vichsec.org\/fr\/wp-json\/wp\/v2\/guideline"}],"about":[{"href":"https:\/\/vichsec.org\/fr\/wp-json\/wp\/v2\/types\/guideline"}],"wp:attachment":[{"href":"https:\/\/vichsec.org\/fr\/wp-json\/wp\/v2\/media?parent=2962"}],"wp:term":[{"taxonomy":"guideline_category","embeddable":true,"href":"https:\/\/vichsec.org\/fr\/wp-json\/wp\/v2\/guideline_category?post=2962"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}